INVO - INVO Bioscience, Inc. Trailing Twelve Months Revenue Growth

INVO Bioscience, Inc. (INVO) is developing a unique embryo maturation method using INVOcell to reduce IVF costs. Data from the GURU.Markets terminal reveals a rolling annual sales growth trend, where 0.00 forms the current metric value. While the struggle to gain trust from physicians and insurers increases pressure, the steady operation of incubator assembly plants supports the company's production capacity.
INVO Bioscience Inc. (INVO) - metric breakdowns and financial figures

This indicator measures revenue dynamics over the last twelve months relative to the same period last year, allowing for the identification of hidden demand erosion prior to the publication of financial reports. By analyzing the year-over-year sales trajectory (TTM), an investor assesses the resilience of INVO Bioscience, Inc. (INVO), where stable growth confirms the effective implementation of INVOcell systems and the conversion of the installed incubator base into recurring revenue from the sale of high-margin consumables.